ARTICLE | Clinical News
Xeloda capecitabine regulatory update
August 2, 2010 7:00 AM UTC
The U.K.'s NICE issued guidance recommending use of Roche's Xeloda capecitabine in combination with a platinum-based regimen for first-line treatment of inoperable advanced gastric cancer. The guidanc...